Presentation TCT 2012 Late Breaking Clinical Trials: Venous Thromboembolic Disease EINSTEIN-PE (Rivaroxaban) Presenter: Jeffrey Kuvin October 23, 2012 REGISTER for free or LOG IN to view this content Venous Presentation TCT 2012 Up Next Presentation TCT 2012 Atrial Fibrillation: 1. CHADS2 vs. CHA2DS2-VASc Risk Assessment. 2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention. Presenter: Peter Brady October 23, 2012 More slides + Presentation TCT 2012 Year in Review: Arrhythmias Presenter: John Camm October 23, 2012 Presentation TCT 2012 Coronary Complication Spectacle: From Air Emboli to Dislodged Stents to No Reflow, Perforations, and More Presenter: John Douglas Jr October 26, 2012 We Recommend
Presentation TCT 2012 Atrial Fibrillation: 1. CHADS2 vs. CHA2DS2-VASc Risk Assessment. 2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention. Presenter: Peter Brady October 23, 2012
Presentation TCT 2012 Coronary Complication Spectacle: From Air Emboli to Dislodged Stents to No Reflow, Perforations, and More Presenter: John Douglas Jr October 26, 2012